Chen H, Engelman A
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Virol. 2000 Sep;74(17):8188-93. doi: 10.1128/jvi.74.17.8188-8193.2000.
Two activities of retroviral integrase, 3' processing and DNA strand transfer, are required to integrate viral cDNA into a host cell chromosome. Integrase activity has been analyzed in vitro using purified protein and recombinant DNA substrates that model the U3 and U5 ends of viral cDNA or by using viral preintegration complexes (PICs) that form during virus infection. Numerous studies have investigated changes in integrase or viral DNA for effects on both 3' processing and DNA strand transfer activities using purified protein, but similar analyses have not been carried out using PICs. Here, we analyzed PICs from human immunodeficiency virus type 1 (HIV-1) strain 604del, an integration-defective mutant lacking 26 bp of U5, and revE1, a revertant of 604del containing an additional 19-bp deletion, for levels of 3' processing activity that occurred in infected cells and for levels of in vitro DNA strand transfer activity. Whereas revE1 supported one-third to one-half of the level of wild-type DNA strand transfer activity, the level of 604del DNA strand transfer activity was undetectable. Surprisingly, integrase similarly processed the 3' ends of 604del and revE1 in vivo. We therefore conclude that 604del is blocked in its ability to replicate in cells after the 3' processing step of retroviral integration. Whereas Western blotting showed that wild-type, revE1, and 604del PICs contained similar levels of integrase protein, Mu-mediated PCR footprinting revealed only minimal protein-DNA complex formation at the ends of 604del cDNA. We propose that 604del is replication defective because proteins important for DNA strand transfer activity do not stably associate with this cDNA after in vivo 3' processing by integrase.
逆转录病毒整合酶的两项活性,即3' 加工和DNA链转移,是将病毒cDNA整合到宿主细胞染色体中所必需的。整合酶活性已通过使用纯化蛋白和模拟病毒cDNA的U3和U5末端的重组DNA底物在体外进行分析,或通过使用病毒感染期间形成的病毒预整合复合物(PIC)进行分析。许多研究使用纯化蛋白研究了整合酶或病毒DNA的变化对3' 加工和DNA链转移活性的影响,但尚未使用PIC进行类似分析。在这里,我们分析了来自1型人类免疫缺陷病毒(HIV-1)毒株604del(一种缺失26 bp U5的整合缺陷突变体)和revE1(604del的回复突变体,包含另外19 bp的缺失)的PIC,以确定感染细胞中发生的3' 加工活性水平和体外DNA链转移活性水平。虽然revE1支持野生型DNA链转移活性水平的三分之一到二分之一,但604del DNA链转移活性水平无法检测到。令人惊讶的是,整合酶在体内类似地加工了604del和revE1的3' 末端。因此,我们得出结论,604del在逆转录病毒整合的3' 加工步骤后在细胞中复制的能力受阻。虽然蛋白质印迹显示野生型、revE1和604del PIC含有相似水平的整合酶蛋白,但Mu介导的PCR足迹分析显示在604del cDNA末端仅形成极少的蛋白质-DNA复合物。我们提出,604del复制缺陷是因为在整合酶体内3' 加工后,对DNA链转移活性重要的蛋白质不能与该cDNA稳定结合。